Chemical Structure (Image 01)
Naratriptan Tablet
Product Images NDC 0054-0278
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naratriptan (NDC 0054-0278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
\\eu.boehringer.com\depts\col\groups\dra-ma\labeling\xml Files\naratriptan HCl Tabs\labels\naratriptan Figure 1.jpg (Image 02)
This appears to be a graph or chart with percentage values and numerical data points, likely representing the probability of a response to different dosages of a medication over time. There are different groups labeled with dosages and sample sizes, and the x-axis appears to represent time in minutes from the initial dose. However, without additional context or a clear visual representation, it is difficult to provide a more specific description or interpretation of this information.*
\\eu.boehringer.com\depts\col\groups\dra-ma\labeling\xml Files\naratriptan HCl Tabs\labels\naratriptan Figure 2.jpg (Image 03)
This data table displays the estimated probability of remedication or rescue over a period of time in hours from the initial dose. The data is divided into three groups: placebo (395 subjects), 1mg (491 subjects), and 25mg (493 subjects). The text does not provide further explanation of what remedication or rescue means.*
Image 04
Each tablet of Naratriptan, USP contains 111mg of naratriptan hydrochloride, equivalent to 1mg of naratriptan. This medication is administered according to the instructions in the Package Insert for Complete Prescribing Information. The tablets should be stored at 20°to 25°C (68° to 77°F) in a room temperature according to USP standards, and distributed by Hikma Pharmaceuticals USA Inc., located in Berkeley Heights, NJ 07922. The medication is available with an NDC identification number of 0054-0278-03 G for the benefit of pharmacists who are expected to dispense it with attached patient information. If you have any inquiries or require additional medication, reach out to Hikma only.*
Image 05
This is a medication label for Naratriptan tablets containing 278 mg of Naratriptan hydrochloride, USP equivalent 102.5 mg of Naratriptan. There is no specific information on usage or prescription available on the label, and the user is advised to see the package insert for complete details. The tablets are to be stored at 20-25°C (68-77°F). It is distributed by Hikma Pharmaceuticals USA Inc. and has an NDC code of 0054-0279-03. The label also includes a message for the pharmacist to dispense the medication only with attached patient information. The last line refers to 'Reony Hikma', however, it is unclear what it is implying.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
